CS
ENFN

Credit Suisse’s Enfusion, Inc. ENFN Stock Holding History

Credit Suisse’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$218K Buy
23,605
+2,059
+10% +$18.1K ﹤0.01% 2890
2023
Q4 		$209K Buy
21,546
+7,389
+52% +$69K ﹤0.01% 2975
2023
Q3 		$127K Sell
14,157
-772
-5% -$7.33K ﹤0.01% 3079
2023
Q2 		$168K Buy
14,929
+3,211
+27% +$28.5K ﹤0.01% 3112
2023
Q1 		$123K Sell
11,718
-19
-0.2% -$209 ﹤0.01% 3186
2022
Q4 		$113K Sell
11,737
-2,473
-17% -$27.8K ﹤0.01% 3310
2022
Q3 		$175K Sell
14,210
-687
-5% -$8.38K ﹤0.01% 3294
2022
Q2 		$153K Buy
+14,897
New +$165K ﹤0.01% 3422

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Credit Suisse's ENFN Position: Q1 2024 in Review

Credit Suisse increased its Enfusion, Inc. (ENFN) stake by 9.6% in Q1 2024, buying an estimated $18.1K and bringing the position to 23,605 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #2890.

Credit Suisse first reported a position in ENFN in Q2 2022 and has held it in 8 quarters since. 95 funds tracked by Wall St. Rank hold ENFN as of Q1 2024.

  • Credit Suisse held 23,605 shares of Enfusion, Inc. worth $218K as of Q1 2024.
  • Credit Suisse bought 2,059 Enfusion, Inc. shares in Q1 2024, an estimated $18.1K.
  • Enfusion, Inc. made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2890 holding.
  • Credit Suisse first reported a position in Enfusion, Inc. in Q2 2022 and has held it in 8 quarters since.
  • 95 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.